Skip to main content Skip to main content
Go to homepage
Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

Screening Patients With Sickle Cell Disease for Kidney Damage Observational Study with Childrens Hospital Medical Center, Cincinnati

Screening Patients With Sickle Cell Disease for Kidney Damage

Description:

For complete details, please visit the study on clinicaltrials.gov 

Study Status:
Closed
Study Sponsor:

Children's Hospital Medical Center, Cincinnati.

Full IRB Study Title:
Screening Patients With Sickle Cell Disease for Kidney Damage
IRB Study ID:
1027584-1
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org
Lead Investigator
Prasad Bodas, MD

Director, Sickle Cell Program; Pediatric Hematologist-Oncologist
Showers Family Center for Childhood Cancer and Blood DisordersHemostasis and Thrombosis CenterSickle Cell ProgramPediatric Stem Cell Transplant Program

Starting Locations:
Career Opportunities
Legal:
Mobile App:

Akron Children's Anywhere:

About Akron Children's

While we are ranked among the best children's hospitals in the country, it's our compassionate approach to treatment that makes us truly exceptional. Through a combination of revolutionary treatments and extraordinary patient experiences, our care does more than heal. It brings the entire family together for emotional support and understanding across multiple locations to reach you in the community where you live. Learn more...

Akron Children's
One Perkins Square, Akron, Ohio 44308-1062
330-543-1000 • webmaster@akronchildrens.org
An Equal Opportunity Employer
Copyright © 2020, Akron Children's. All Rights Reserved.
  • Magnet Recongnition
  • Newsweek: World's Best Hospitals - 2023
  • Newsweek: World's Best Hospitals - Pediatrics 2023

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.